HUL Q1 Review - In-line; Inflation To Be The Chief Concern: IDBI Capital
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
IDBI Capital Report
Hindustan Unilever Ltd.'s Q1 FY22 result was in line with our estimates.
Resiliency in demand for health, hygiene and nutrition portfolio helped HUL to protect decline in revenue growth (compared to Q4 FY21) due to impact of second wave induced lockdowns.
Revenue from discretionary and out of home consumption portfolio impacted significantly. Demand from rural outperformed urban during the quarter.
Positively the company has taken 3% price hike in respective product portfolio to mitigate the impact of inflation.
Further, premium portfolio is growing at two times compared to other products; this should be more margin accretive.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.